CONTACT US
EisnerAmper Director of Capital Markets discusses venture capital, VC investment, unicorn companies, IPO activity, fundraising and exit values.

Venture Capital Breaks a Record in 2018

   

It was a record-setting year for venture capital as well as exits in 2018. EisnerAmper Director of Capital Markets Alan Wink breaks it down and discusses if VC investment can keep up this furious pace in 2019.


Transcript

Dave Plaskow: Hello and welcome to the EisnerAmper podcast series. We're always interested in the latest trends and developments as well as any related business and accounting opportunities and challenges. Today we're taking a look at the venture capital landscape for the fourth quarter of 2018. I'm your host Dave Plaskow and with us today, as always, is Alan Wink, a Director in EisnerAmper’s Capital Markets. Alan, welcome and thanks for being here.
Alan Wink: Good morning Dave.


More Podcasts in This Series
Are We on Track for a $100 Billion in VC Investment for 2018?

EisnerAmper's Director of Capital Markets examines venture capital VC investment for the third quarter (Q3) of 2018. Companies continue to raise large pools of private capital and 2019 might be the year of the IPO and climbing stock prices with Uber and Airbnb.


A Look at the NJ Innovation Evergreen Fund

Governor Murphy’s Evergreen Fund in New Jersey will raise venture capital funding through tax credits. Companies in technology and life sciences can receive funding if the pass venture capital investor scrutiny and are located in New Jersey, providing little risk for investment.


Venture Capitals Tread Cautiously Due to High Valuations

This episode of EisnerAmper’s podcast series has the director of Capital Markets discuss the venture capital market for the first half of 2018, including fintech, valuations, M&A, artificial intelligence, IPO's, Apple's $1 billion valuation and the VC market in general.



About Alan Wink

Mr. Wink assists clients with capital budgeting, capital structuring and capital sourcing. He has worked with many tech and life science companies on developing the appropriate capital structure for their position in the business life cycle.

Contact Alan

* Required